土家药血通的植物化学与药理作用综述
该综述系统梳理了土家药血通(Kadsura heteroclita)的植物分布、传统用途、化学成分、药理活性、毒性与质量控制。从茎中鉴定出187种化学成分,以木脂素和三萜类为主;提取物及单体显示抗类风湿关节炎、抗炎镇痛、保肝、抗HIV、抗癌和抗HBV等活性。三萜成分Schisanlactone E(血通素)具有抗癌、神经保护及抗神经炎症活性,且治疗剂量范围内安全无毒。
要点
- 血通传统用于类风湿关节炎、肝炎及肌肉关节痉挛,现代药理验证其抗RA与抗炎镇痛作用。
- 茎中已鉴定187种化学成分,木脂素和三萜类为主要活性成分群。
- Schisanlactone E(血通素)具抗癌、神经保护与抗神经炎症活性,治疗剂量内安全。
核心结论
- 药理研究验证了血通在中医中的传统用途,木脂素和三萜类可能介导其大部分生物活性。
- 该植物在发现更具活性的次级代谢产物方面潜力巨大,需对其他部位开展进一步植物化学与生物学研究。
研究设计与样本
- 综述通过PubMed、CNKI、Scifinder、Google Scholar、百度学术及土家医药典籍等数据库与文献来源收集资料。
- 收集内容涵盖植物分布与描述、传统用途、植物化学、药理活性、毒性和质量控制。
主要发现
- 血通茎的植物化学研究鉴定出187种化学成分,其中木脂素和三萜类为优势组。
- 分离物和粗提物在体内外显示抗RA、抗炎镇痛、保肝、抗HIV、抗癌和抗HBV等广泛药理活性。
- 三萜Schisanlactone E(血通素)是血通主要成分之一,具抗癌、神经保护和抗神经炎症活性。
- 该植物在治疗剂量范围内安全无毒。
临床怎么用
- 血通传统用于类风湿关节炎、肝炎及肌肉关节痉挛,其抗RA与抗炎镇痛活性已有药理证据支持。
- 木脂素和三萜类可作为质量标志物候选,但综述未给出具体质量控制阈值或含量限度。
局限性
- 综述以文献汇总为主,未报告原始研究的样本量、效应量或统计显著性。
- 多数药理数据来自临床前研究,缺乏临床疗效与安全性验证。
- 植物其他部位的化学成分与生物活性尚未充分研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Kadsura heteroclita (Roxb.) Craib (traditionally known as "Xue Tong") is an important member of the economically and medicinally important plant family Schisandraceae. "Xue Tong" is an imperative ingredient of the Tujia ethnomedicine, traditionally used for the treatment of rheumatoid arthritis (RA), hepatitis, and muscles and joint spasm. The plant is known to be a rich source of lignans and triterpenoids. These classes of natural products have been known to possess various pharmacological activities. AIM OF REVIEW: This review was motivated by the importance of K. heteroclita in traditional Chinese medicine (TCM). It aims to compile the available information on its botanical distribution and description, traditional uses, phytochemistry, pharmacological activities, toxicity, and quality control to provide a solid base for further research and development. MATERIALS AND METHODS: Relevant literature was collected by several scientific databases including PubMed, CNKI, Scifinder, The Plant List, Google Scholar, Baidu Scholar, Books (Tujia pharmaceutical records, Guangxi Chinese herbal medicine, Hunan pharmaceutical records and Field identification manual of Chinese herbal medicine) and other literature sources (Flora of China, Pharmacopoeia of the People's Republic of China) which helped in collecting maximum data about the studied species. RESULTS: Traditional uses of K. heteroclita have proven its medicinal importance, providing a rationale for scientific research. Phytochemical studies on the stem of K. heteroclita resulted in the identification of 187 chemical constituents, among which lignans and triterpenoids are the predominant groups. The isolates and crude extracts have been found to exhibit a wide spectrum of in vivo and in vitro pharmacological activities such as anti-RA, anti-inflammatory and analgesic, hepatoprotection, anti-HIV, anti-cancer and anti-HBV. Schisanlactone E (xuetongsu), a triterpenoid, is one of the major components of K. heteroclita exhibiting anti-cancer, neuroprotective and anti-neuroinflammation activities. Interestingly and luckily, this plant has been found to be safe and non-toxic within the therapeutic dose range. CONCLUSION: Pharmacological investigations have validated the use of K. heteroclita in traditional Chinese medicine (TCM). Literature review has demonstrated that lignans and triterpenoids are possibly responsible for most of the biological activities exhibited by this plant. To conclude, this plant shows immense potential for the discovery of more potent bioactive secondary metabolites and therefore further phytochemical and biological studies on other parts of K. heteroclita need to be conducted and more compounds need to be tested regarding their biological activities to completely explore its value as a tremendously important medicinal plant species.
引用
- Wang M, Jiang S, Yuan H, et al. A review of the phytochemistry and pharmacology of Kadsura heteroclita, an important plant in Tujia ethnomedicine. J Ethnopharmacol. 2020. PMID: 33171272. doi:10.1016/j.jep.2020.113567
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。